167 related articles for article (PubMed ID: 19900828)
1. Vasculopathy in patients with Fabry disease: current controversies and research directions.
Rombach SM; Twickler TB; Aerts JM; Linthorst GE; Wijburg FA; Hollak CE
Mol Genet Metab; 2010 Feb; 99(2):99-108. PubMed ID: 19900828
[TBL] [Abstract][Full Text] [Related]
2. Anderson-Fabry disease: a multiorgan disease.
Tuttolomondo A; Pecoraro R; Simonetta I; Miceli S; Pinto A; Licata G
Curr Pharm Des; 2013; 19(33):5974-96. PubMed ID: 23448451
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor (VEGF-a) in Fabry disease: association with cutaneous and systemic manifestations with vascular involvement.
Zampetti A; Gnarra M; Borsini W; Giurdanella F; Antuzzi D; Piras A; Smaldone C; Pieroni M; Cadeddu C; de Waure C; Feliciani C
Cytokine; 2013 Mar; 61(3):933-9. PubMed ID: 23332617
[TBL] [Abstract][Full Text] [Related]
4. Anderson-Fabry disease: developments in diagnosis and treatment.
Kes VB; Cesarik M; Zavoreo I; Madzar Z; Demarin V
Acta Clin Croat; 2012 Sep; 51(3):411-7. PubMed ID: 23330407
[TBL] [Abstract][Full Text] [Related]
5. [Molecular pathology and clinical manifestations of Fabry disease].
Rákóczi E; Görögh S; Grubits J; Erdos M; Garzuly F; Hahn K; Bencsik K; Vécsei L; Trinn C; Kristóf E; Mogyorósy G; Tóth B; Maródi L
Orv Hetil; 2007 Jun; 148(23):1087-94. PubMed ID: 17545117
[TBL] [Abstract][Full Text] [Related]
6. Fabry disease in patients with hypertrophic cardiomyopathy (HCM).
Beer G; Reinecke P; Gabbert HE; Hort W; Kuhn H
Z Kardiol; 2002 Dec; 91(12):992-1002. PubMed ID: 12490989
[TBL] [Abstract][Full Text] [Related]
7. End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry.
Ortiz A; Cianciaruso B; Cizmarik M; Germain DP; Mignani R; Oliveira JP; Villalobos J; Vujkovac B; Waldek S; Wanner C; Warnock DG
Nephrol Dial Transplant; 2010 Mar; 25(3):769-75. PubMed ID: 19846394
[TBL] [Abstract][Full Text] [Related]
8. [End-stage cardiac manifestations and autopsy findings in patients with cardiac fabry disease].
Teraguchi H; Takenaka T; Yoshida A; Taguchi S; Ninomiya K; Yoshida H; Horinouchi M; Yonezawa S; Nakao S; Minagoe S; Tei S
J Cardiol; 2004 Feb; 43(2):98-9. PubMed ID: 15046052
[TBL] [Abstract][Full Text] [Related]
9. Fabry disease: cardiac manifestations and therapeutic options.
Pierre-Louis B; Kumar A; Frishman WH
Cardiol Rev; 2009; 17(1):31-5. PubMed ID: 19092368
[TBL] [Abstract][Full Text] [Related]
10. Nailfold capillaroscopy: Specific features in Fabry disease.
Wasik JS; Simon RW; Meier T; Steinmann B; Amann-Vesti BR
Clin Hemorheol Microcirc; 2009; 42(2):99-106. PubMed ID: 19433883
[TBL] [Abstract][Full Text] [Related]
11. Fabry disease: molecular genetics of the inherited nephropathy.
Desnick RJ; Astrin KH; Bishop DF
Adv Nephrol Necker Hosp; 1989; 18():113-27. PubMed ID: 2564247
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of Vascular Phenotype in Fabry Patients.
Vujkovac AC; Vujkovac B; Novaković S; Števanec M; Šabovič M
Angiology; 2021 May; 72(5):426-433. PubMed ID: 33342225
[TBL] [Abstract][Full Text] [Related]
13. Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
Takenaka T; Teraguchi H; Yoshida A; Taguchi S; Ninomiya K; Umekita Y; Yoshida H; Horinouchi M; Tabata K; Yonezawa S; Yoshimitsu M; Higuchi K; Nakao S; Anan R; Minagoe S; Tei C
J Cardiol; 2008 Feb; 51(1):50-9. PubMed ID: 18522775
[TBL] [Abstract][Full Text] [Related]
14. Later-onset Fabry disease: an adult variant presenting with the cramp-fasciculation syndrome.
Nance CS; Klein CJ; Banikazemi M; Dikman SH; Phelps RG; McArthur JC; Rodriguez M; Desnick RJ
Arch Neurol; 2006 Mar; 63(3):453-7. PubMed ID: 16533976
[TBL] [Abstract][Full Text] [Related]
15. Fabry disease--a primer for cardiologists.
Mursă A; Ginghină C; Jurcut R
Rom J Intern Med; 2014; 52(4):216-22. PubMed ID: 25726623
[TBL] [Abstract][Full Text] [Related]
16. Cardiac microvascular pathology in Fabry disease: evaluation of endomyocardial biopsies before and after enzyme replacement therapy.
Thurberg BL; Fallon JT; Mitchell R; Aretz T; Gordon RE; O'Callaghan MW
Circulation; 2009 May; 119(19):2561-7. PubMed ID: 19414635
[TBL] [Abstract][Full Text] [Related]
17. Anderson-Fabry disease and the heart.
O'Mahony C; Elliott P
Prog Cardiovasc Dis; 2010; 52(4):326-35. PubMed ID: 20109602
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of patients with Fabry disease in Argentina].
AADELFA (Asociación Argentina de estudio de enfermedad de Fabry y otras enfermedades lisosomales)
Medicina (B Aires); 2010; 70(1):37-43. PubMed ID: 20228022
[TBL] [Abstract][Full Text] [Related]
19. Fabry disease in mice is associated with age-dependent susceptibility to vascular thrombosis.
Eitzman DT; Bodary PF; Shen Y; Khairallah CG; Wild SR; Abe A; Shaffer-Hartman J; Shayman JA
J Am Soc Nephrol; 2003 Feb; 14(2):298-302. PubMed ID: 12538729
[TBL] [Abstract][Full Text] [Related]
20. Fabry disease: clinical spectrum and evidence-based enzyme replacement therapy.
Desnick RJ; Banikazemi M
Nephrol Ther; 2006 Jan; 2 Suppl 2():S172-85. PubMed ID: 17373219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
